These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 30390633)
1. The significance of anti-neuronal antibodies for acute psychiatric disorders: a retrospective case-controlled study. Schou MB; Sæther SG; Drange OK; Krane-Gartiser K; Reitan SK; Vaaler AE; Kondziella D BMC Neurosci; 2018 Nov; 19(1):68. PubMed ID: 30390633 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care. Schou M; Sæther SG; Borowski K; Teegen B; Kondziella D; Stoecker W; Vaaler A; Reitan SK Psychol Med; 2016 Dec; 46(16):3303-3313. PubMed ID: 27609625 [TBL] [Abstract][Full Text] [Related]
3. A prospective three-year follow-up study on the clinical significance of anti-neuronal antibodies in acute psychiatric disorders. Schou MB; Sæther SG; Drange OK; Brenner E; Crespi J; Eikenes L; Mykland MS; Pintzka C; Håberg AK; Sand T; Vaaler A; Kondziella D Sci Rep; 2019 Dec; 10(1):35. PubMed ID: 31896766 [TBL] [Abstract][Full Text] [Related]
4. Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy. Wright S; Geerts AT; Jol-van der Zijde CM; Jacobson L; Lang B; Waters P; van Tol MJ; Stroink H; Neuteboom RF; Brouwer OF; Vincent A Epilepsia; 2016 May; 57(5):823-31. PubMed ID: 26996997 [TBL] [Abstract][Full Text] [Related]
5. Routine diagnostics for neural antibodies, clinical correlates, treatment and functional outcome. Bien CG; Bien CI; Dogan Onugoren M; De Simoni D; Eigler V; Haensch CA; Holtkamp M; Ismail FS; Kurthen M; Melzer N; Mayer K; von Podewils F; Rauschka H; Rossetti AO; Schäbitz WR; Simova O; Witt K; Höftberger R; May TW J Neurol; 2020 Jul; 267(7):2101-2114. PubMed ID: 32246252 [TBL] [Abstract][Full Text] [Related]
6. Anti-neuronal anti-bodies in patients with early psychosis. Mantere O; Saarela M; Kieseppä T; Raij T; Mäntylä T; Lindgren M; Rikandi E; Stoecker W; Teegen B; Suvisaari J Schizophr Res; 2018 Feb; 192():404-407. PubMed ID: 28461116 [TBL] [Abstract][Full Text] [Related]
7. Comparisons between Psychiatric Symptoms of Patients with Anti-NMDAR Encephalitis and New-Onset Psychiatric Patients. Wang J; Zhang B; Zhang M; Chen J; Deng H; Wang Q; Sun X Neuropsychobiology; 2017; 75(2):72-80. PubMed ID: 29065417 [TBL] [Abstract][Full Text] [Related]
8. Distinction between anti-VGKC-complex seropositive patients with and without anti-LGI1/CASPR2 antibodies. Yeo T; Chen Z; Yong KP; Wong PYW; Chai JYH; Tan K J Neurol Sci; 2018 Aug; 391():64-71. PubMed ID: 30103974 [TBL] [Abstract][Full Text] [Related]
9. Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings. Baysal-Kirac L; Tuzun E; Erdag E; Ulusoy C; Vanli-Yavuz EN; Ekizoglu E; Peach S; Sezgin M; Bebek N; Gurses C; Gokyigit A; Vincent A; Baykan B J Neurol; 2016 Mar; 263(3):455-66. PubMed ID: 26725084 [TBL] [Abstract][Full Text] [Related]
10. Mesial temporal lobe epilepsy with hippocampal sclerosis is infrequently associated with neuronal autoantibodies. Nóbrega-Jr AW; Gregory CP; Schlindwein-Zanini R; Neves FS; Wolf P; Walz R; Steindel M; Lin K Epilepsia; 2018 Sep; 59(9):e152-e156. PubMed ID: 30146688 [TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to neuronal antigens in children with focal epilepsy and no prima facie signs of encephalitis. Borusiak P; Bettendorf U; Wiegand G; Bast T; Kluger G; Philippi H; Münstermann D; Bien CG Eur J Paediatr Neurol; 2016 Jul; 20(4):573-9. PubMed ID: 27056280 [TBL] [Abstract][Full Text] [Related]
13. CASPR2 autoantibodies are raised during pregnancy in mothers of children with mental retardation and disorders of psychological development but not autism. Coutinho E; Jacobson L; Pedersen MG; Benros ME; Nørgaard-Pedersen B; Mortensen PB; Harrison PJ; Vincent A J Neurol Neurosurg Psychiatry; 2017 Sep; 88(9):718-721. PubMed ID: 28572274 [TBL] [Abstract][Full Text] [Related]
14. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. Steiner J; Walter M; Glanz W; Sarnyai Z; Bernstein HG; Vielhaber S; Kästner A; Skalej M; Jordan W; Schiltz K; Klingbeil C; Wandinger KP; Bogerts B; Stoecker W JAMA Psychiatry; 2013 Mar; 70(3):271-8. PubMed ID: 23344076 [TBL] [Abstract][Full Text] [Related]